Merit Medical Systems, Inc. (MMSI)

NASDAQ • Healthcare

$93.94

+$2.53 (+2.8%)

Market closed

Last close at October 22, 2026 at 20:00 UTC

Open$91.72

Day Range$89.13 - $94.16

Avg. Volume (3M)618.2K

Market Cap$5.6B

P/E Ratio38.3

52 Week Range

$59.74$94.75

Next EarningsIn 7 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$418.8M100%

Gross Profitminus cost of goods$215.1M51%

Operating Incomeminus R&D and overhead$60.5M14%

Net Incomeminus taxes and the rest$38.8M9%

In plain terms: out of every $100 in revenue, Merit Medical Systems, Inc. keeps $9 as net profit.

Fundamentals & Financials

Revenue (TTM)

$1.5B

Net Income (TTM)

$145.5M

EPS (TTM)

$2.45

ROA (TTM)

5.08%

Current Ratio

4.2

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+17.4%Q3 2025$1.01

+12.2%Q4 2025$0.92

+8.3%Q1 2026$1.04

+11.9%Q2 2026$0.94

+24.1%Q3 2026$1.19

Oct 29

in 7 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +24.1%

Merit Medical Systems beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 30, 2026, with adjusted EPS of $1.19 topping the $0.96 estimate (+24%) and revenue of $418.8 million topping the $405.2 million estimate (+3.4%). Revenue rose about 10% to roughly $418.8 million from about $382.0 million a year ago, supported by its mix of cardiovascular and endoscopy-focused medical devices and supplies, while net income increased about 19% to roughly $38.8 million from about $32.6 million. Profitability was reflected in a gross margin of ~51% and operating margin of roughly 15%, with operating income of about $60.5 million. The quarter also generated operating cash flow of roughly $69.3 million. For the next period, consensus calls for EPS of $1.04 on revenue of $410.4 million.

Next report — what to expect

Merit Medical Systems, Inc. (MMSI) reports next on October 29, 2026. Wall Street is looking for EPS of $1.04 on revenue of $410.4 million. For trailing context, revenue grew +9.7% year over year last quarter. MMSI has beaten EPS in 8 of 8 most recent quarters.

View full earnings history

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. develops and sells medical devices and supplies for hospital and clinical procedures, trading on NASDAQ under MMSI. The company operates in the healthcare equipment field, with $1.5 billion in revenue in FY2025, and its product lines span cardiovascular and endoscopy settings across the United States and international markets.

Name

Merit Medical Systems, Inc.

CEO

Martha Goldberg Aronson

Website

www.merit.com

Industry

Healthcare

Year Founded

1987

Employees

7,500

Today's Snapshot

AI-generated

MMSI closed 2.8% higher at 93.94, close to its 52-week high of 94.75. Earnings are due from MMSI on 29 October.

Trading Volume

Above 10d avg 633.9K

642.4K

vs S&P 500 Today

Strong Outperformance

+4.04%

Updated: October 22, 2026 at 20:08 UTC

Technical Indicators

6 Buy1 Neutral1 Sell

MMSI is trading well above its short, medium and long-term moving averages and ADX signals a healthy trend, supported by positive MACD and a robust OBV reading that indicates accumulation. Momentum indicators are strong though some oscillators are nearing extended levels, and ATR shows only moderate volatility while the upper Bollinger band suggests price is toward the range top. The pivot lies slightly below current price, offering minor near-term support. Technical takeaway: broad moving-average alignment, trend strength and rising volume support a strong buy technical posture.

All signals